Acadia Pharmaceuticals (ACAD) PT Raised to $70 at Cantor Fitzgerald
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 20.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.57 | 52 Week High | $42.49 | |||
| Open | $20.57 | 52 Week Low | $16.64 | |||
| Day High | $20.57 | P/E | N/A | |||
| Day Low | $20.57 | EPS | $-0.42 | |||
| Volume | 18,593 | |||||
